The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of an anti-CD20-interleukin-2 immunocytokine DI-Leu16-IL2 in patients with relapsed b-cell lymphoma (NHL).
 
Frederick Lansigan
No Relationships to Disclose
 
Ryotaro Nakamura
Research Funding - Fresenius Biotech (Inst); Helocyte (Inst); Pharmacyclics (Inst)
 
Donald Quick
No Relationships to Disclose
 
Daniel Vlock
Employment - Alopexx ; Alopexx (I)
Leadership - Alopexx ; Alopexx ; Alopexx ; Alopexx (I); Cognoptix; Kolltan Pharmaceuticals; Valerion Therapeutics, LLC
 
Andrew Antony Raubitschek
No Relationships to Disclose
 
Stephen D Gillies
Employment - Alopexx ; Provenance Biopharmaceuticals
Leadership - Alopexx ; Provenance Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - Alopexx ; Provenance Biopharmaceuticals
 
Veronika Bachanova
Consulting or Advisory Role - Seagen; Spectrum Pharmaceuticals
Research Funding - Novartis